Functional Coupling of β3-Adrenoceptors and Large Conductance Calcium-Activated Potassium Channels in Human Uterine Myocytes
Context: β3-Adrenoreceptor modulation in human myometrium during pregnancy is linked functionally to myometrial inhibition. Maxi-K+ channels (BKCa) play a significant role in modulating cell membrane potential and excitability. Objective: This study was designed to investigate the potential involvement of BKCa channel function in the response of human myometrium to β3-adrenoceptor activation. Design: Single and whole-cell electrophysiological BKCa channel recordings from freshly dispersed myocytes were obtained in the presence and absence of BRL37344, a specific β3-adrenoreceptor agonist. The in vitro effects of BRL37344 on isolated myometrial contractions, in the presence and absence of the specific BKCa channel blocker, iberiotoxin (IbTX), were investigated. Setting: The study was carried out at the Clinical Science Institute. Patients or Other Participants: Myometrial biopsies were obtained at elective cesarean delivery. Intervention: No intervention was applied. Main Outcome Measures: Open state probability of single channel recordings, whole cell currents, and myometrial contractile activity were measured. Results: Single-channel recordings identified the BKCa channel as a target of BRL37344. BRL37344 significantly increased the open state probability of this channel in a concentration-dependent manner (control 0.031 ± 0.004; 50 μm BRL37344 0.073 ± 0.005 (P < 0.001); and 100 μm BRL37344 0.101 ± 0.005 (P < 0.001). This effect was completely blocked after preincubation of the cells with 1 μm bupranolol, a nonspecific β-adrenoreceptor blocker, or 100 nm SR59230a, a specific β3-adrenoreceptor antagonist. In addition, BRL37344 increased whole-cell currents over a range of membrane potentials, and this effect was reversed by 100 nm IbTX. In vitro isometric tension studies demonstrated that BRL37344 exerted a significant concentration-dependent relaxant effect on human myometrial tissue (P < 0.05), and preincubation of these strips with IbTX attenuated this effect on both spontaneous and oxytocin-induced contractions (44.44 and 57.84% at 10−5m, respectively). Conclusions: These findings outline that activation of the BKCa channel may explain the potent uterorelaxant effect of β3-adrenoreceptor agonists.